KEQU
Kewaunee Scientific Corporation
Furnishings, Fixtures & Appliances
Market Cap$105M
5Y Perf.+282.0%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
KEQU vs AMZN
Revenue, margins, valuation, and 5-year total return — side by side.
AMZN
Amazon.com, Inc.
Specialty Retail
Market Cap$2.92T
5Y Perf.+122.1%
KEQU vs AMZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | KEQU | AMZN |
|---|---|---|
| Industry | Furnishings, Fixtures & Appliances | Specialty Retail |
| Market Cap | $105M | $2.92T |
| Revenue (TTM) | $288M | $742.78B |
| Net Income (TTM) | $11M | $90.80B |
| Gross Margin | 28.9% | 50.6% |
| Operating Margin | 7.0% | 11.5% |
| Forward P/E | 23.8x | 34.8x |
| Total Debt | $50M | $152.99B |
| Cash & Equiv. | $15M | $86.81B |
KEQU vs AMZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
KEQU
AMZN
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Kewaunee Scientific… (KEQU) | 100 | 382.0 | +282.0% |
| Amazon.com, Inc. (AMZN) | 100 | 222.1 | +122.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KEQU vs AMZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: KEQU and AMZN are tied at the top with 3 categories each — the right choice depends on your priorities. Amazon.com, Inc. is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
KEQU
Kewaunee Scientific Corporation
The Income Pick
KEQU has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- Dividend streak 0 yrs, beta 1.09
- Rev growth 18.0%, EPS growth -40.0%, 3Y rev CAGR 12.5%
- Lower volatility, beta 1.09, Low D/E 75.7%, current ratio 2.20x
Best for: income & stability and growth exposure
AMZN
Amazon.com, Inc.
The Long-Run Compounder
AMZN is the clearest fit if your priority is long-term compounding.
- 7.0% 10Y total return vs KEQU's 138.9%
- 12.2% margin vs KEQU's 3.9%
- +43.7% vs KEQU's +12.2%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | KEQU | 18.0% revenue growth vs AMZN's 12.4% |
| Value | KEQU | Lower P/E (23.8x vs 34.8x) |
| Quality / Margins | AMZN | 12.2% margin vs KEQU's 3.9% |
| Stability / Safety | KEQU | Beta 1.09 vs AMZN's 1.51 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | AMZN | +43.7% vs KEQU's +12.2% |
| Efficiency (ROA) | AMZN | 11.5% ROA vs KEQU's 5.9%, ROIC 14.7% vs 18.3% |
KEQU vs AMZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
KEQU vs AMZN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLAMZNLAGGINGKEQU
KEQUKewaunee Scientific C…
1leads
AMZNAmazon.com, Inc.
3leads
6 Total Categories
CATEGORYLEADERvs KEQUMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
AMZN5/6
Valuation MetricsMultiples, price ratios, and targets
KEQU6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
AMZN6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
AMZN5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
AMZN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 2581.4x KEQU's $288M. AMZN is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to KEQU's 3.9%. On growth, AMZN holds the edge at +16.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | KEQUKewaunee Scientif… | AMZNAmazon.com, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $288M | $742.8B |
| EBITDAEarnings before interest/tax | $26M | $155.9B |
| Net IncomeAfter-tax profit | $11M | $90.8B |
| Free Cash FlowCash after capex | $19M | -$2.5B |
| Gross MarginGross profit ÷ Revenue | +28.9% | +50.6% |
| Operating MarginEBIT ÷ Revenue | +7.0% | +11.5% |
| Net MarginNet income ÷ Revenue | +3.9% | +12.2% |
| FCF MarginFCF ÷ Revenue | +6.6% | -0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.3% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -48.9% | +74.8% |
AMZN leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
KEQU leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 9.5x trailing earnings, KEQU trades at a 75% valuation discount to AMZN's 37.8x P/E. On an enterprise value basis, KEQU's 6.2x EV/EBITDA is more attractive than AMZN's 20.5x.
| Metric | KEQUKewaunee Scientif… | AMZNAmazon.com, Inc. |
|---|---|---|
| Market CapShares × price | $105M | $2.92T |
| Enterprise ValueMkt cap + debt − cash | $140M | $2.98T |
| Trailing P/EPrice ÷ TTM EPS | 9.52x | 37.82x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.84x | 34.77x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.35x |
| EV / EBITDAEnterprise value multiple | 6.21x | 20.47x |
| Price / SalesMarket cap ÷ Revenue | 0.43x | 4.07x |
| Price / BookPrice ÷ Book value/share | 1.64x | 7.14x |
| Price / FCFMarket cap ÷ FCF | 8.29x | 378.98x |
KEQU leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
AMZN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
AMZN delivers a 23.3% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $16 for KEQU. AMZN carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to KEQU's 0.76x. On the Piotroski fundamental quality scale (0–9), AMZN scores 6/9 vs KEQU's 4/9, reflecting solid financial health.
| Metric | KEQUKewaunee Scientif… | AMZNAmazon.com, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +15.9% | +23.3% |
| ROA (TTM)Return on assets | +5.9% | +11.5% |
| ROICReturn on invested capital | +18.3% | +14.7% |
| ROCEReturn on capital employed | +15.1% | +15.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.76x | 0.37x |
| Net DebtTotal debt minus cash | $35M | $66.2B |
| Cash & Equiv.Liquid assets | $15M | $86.8B |
| Total DebtShort + long-term debt | $50M | $153.0B |
| Interest CoverageEBIT ÷ Interest expense | 4.64x | 39.96x |
AMZN leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KEQU five years ago would be worth $30,274 today (with dividends reinvested), compared to $16,476 for AMZN. Over the past 12 months, AMZN leads with a +43.7% total return vs KEQU's +12.2%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs KEQU's 31.6% — a key indicator of consistent wealth creation.
| Metric | KEQUKewaunee Scientif… | AMZNAmazon.com, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -2.7% | +19.7% |
| 1-Year ReturnPast 12 months | +12.2% | +43.7% |
| 3-Year ReturnCumulative with dividends | +128.0% | +156.2% |
| 5-Year ReturnCumulative with dividends | +202.7% | +64.8% |
| 10-Year ReturnCumulative with dividends | +138.9% | +697.8% |
| CAGR (3Y)Annualised 3-year return | +31.6% | +36.8% |
AMZN leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — KEQU and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
KEQU is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than AMZN's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs KEQU's 59.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | KEQUKewaunee Scientif… | AMZNAmazon.com, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.09x | 1.51x |
| 52-Week HighHighest price in past year | $60.89 | $278.56 |
| 52-Week LowLowest price in past year | $30.78 | $185.01 |
| % of 52W HighCurrent price vs 52-week peak | +59.9% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 52.1 | 81.1 |
| Avg Volume (50D)Average daily shares traded | 5K | 45.5M |
Evenly matched — KEQU and AMZN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | KEQUKewaunee Scientif… | AMZNAmazon.com, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $306.77 |
| # AnalystsCovering analysts | — | 94 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
AMZN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). KEQU leads in 1 (Valuation Metrics). 1 tied.
Best OverallAmazon.com, Inc. (AMZN)Leads 3 of 6 categories
Loading custom metrics...
KEQU vs AMZN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is KEQU or AMZN a better buy right now?
For growth investors, Kewaunee Scientific Corporation (KEQU) is the stronger pick with 18.
0% revenue growth year-over-year, versus 12. 4% for Amazon. com, Inc. (AMZN). Kewaunee Scientific Corporation (KEQU) offers the better valuation at 9. 5x trailing P/E (23. 8x forward), making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KEQU or AMZN?
On trailing P/E, Kewaunee Scientific Corporation (KEQU) is the cheapest at 9.
5x versus Amazon. com, Inc. at 37. 8x. On forward P/E, Kewaunee Scientific Corporation is actually cheaper at 23. 8x.
03Which is the better long-term investment — KEQU or AMZN?
Over the past 5 years, Kewaunee Scientific Corporation (KEQU) delivered a total return of +202.
7%, compared to +64. 8% for Amazon. com, Inc. (AMZN). Over 10 years, the gap is even starker: AMZN returned +697. 8% versus KEQU's +138. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KEQU or AMZN?
By beta (market sensitivity over 5 years), Kewaunee Scientific Corporation (KEQU) is the lower-risk stock at 1.
09β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately 38% more volatile than KEQU relative to the S&P 500. On balance sheet safety, Amazon. com, Inc. (AMZN) carries a lower debt/equity ratio of 37% versus 76% for Kewaunee Scientific Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — KEQU or AMZN?
By revenue growth (latest reported year), Kewaunee Scientific Corporation (KEQU) is pulling ahead at 18.
0% versus 12. 4% for Amazon. com, Inc. (AMZN). On earnings-per-share growth, the picture is similar: Amazon. com, Inc. grew EPS 29. 7% year-over-year, compared to -40. 0% for Kewaunee Scientific Corporation. Over a 3-year CAGR, KEQU leads at 12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KEQU or AMZN?
Amazon.
com, Inc. (AMZN) is the more profitable company, earning 10. 8% net margin versus 4. 7% for Kewaunee Scientific Corporation — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMZN leads at 11. 2% versus 7. 4% for KEQU. At the gross margin level — before operating expenses — AMZN leads at 50. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KEQU or AMZN more undervalued right now?
On forward earnings alone, Kewaunee Scientific Corporation (KEQU) trades at 23.
8x forward P/E versus 34. 8x for Amazon. com, Inc. — 10. 9x cheaper on a one-year earnings basis.
08Which pays a better dividend — KEQU or AMZN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is KEQU or AMZN better for a retirement portfolio?
For long-horizon retirement investors, Amazon.
com, Inc. (AMZN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+697. 8% 10Y return). Both have compounded well over 10 years (AMZN: +697. 8%, KEQU: +138. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KEQU and AMZN?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KEQU is a small-cap high-growth stock; AMZN is a mega-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(KEQU: 3.3% · AMZN: 16.6%)Net Margin>
%
(KEQU: 3.9% · AMZN: 12.2%)P/E Ratio<
x
(KEQU: 9.5x · AMZN: 37.8x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.